BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 332 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -14.3% | 50 | 0.0% | 0.01% | -9.1% |
| Q4 2021 | $7,000 | 0.0% | 50 | 0.0% | 0.01% | -8.3% |
| Q3 2021 | $7,000 | +250.0% | 50 | +4.2% | 0.01% | +500.0% |
| Q2 2019 | $2,000 | 0.0% | 48 | +17.1% | 0.00% | -33.3% |
| Q4 2018 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $2,000 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |